日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

The Safety, Tolerability, and Pharmacokinetics of ALT-BB4 (A Novel Recombinant Hyaluronidase): A Randomized, Double-Blinded, Placebo-Controlled, Phase 1 Study in Healthy Volunteers

ALT-BB4(一种新型重组透明质酸酶)的安全性、耐受性和药代动力学:一项在健康志愿者中进行的随机、双盲、安慰剂对照的1期研究

Lee, Ji Su; Kim, WonSerk; Won, Chong-Hyun; Lee, Yang-Won; Lee, SeungHwan; Won, Heejae; Park, Soon-Jae; Lee, Sunbae; Kim, Seol-Hee; Yang, Jiwon; Bahn, Gahee; Lee, Dong Hun

Monomeric and dimeric models of ERK2 in conjunction with studies on cellular localization, nuclear translocation, and in vitro analysis

ERK2的单体和二聚体模型,结合细胞定位、核转位和体外分析的研究

Lee, Sunbae; Bae, Yun Soo

Development of JNK2-selective peptide inhibitors that inhibit breast cancer cell migration

开发抑制乳腺癌细胞迁移的JNK2选择性肽抑制剂

Kaoud, Tamer S; Mitra, Shreya; Lee, Sunbae; Taliaferro, Juliana; Cantrell, Michael; Linse, Klaus D; Van Den Berg, Carla L; Dalby, Kevin N

Solution NMR insights into docking interactions involving inactive ERK2

溶液核磁共振对涉及非活性ERK2的对接相互作用的深入研究

Piserchio, Andrea; Warthaka, Mangalika; Devkota, Ashwini K; Kaoud, Tamer S; Lee, Sunbae; Abramczyk, Olga; Ren, Pengyu; Dalby, Kevin N; Ghose, Ranajeet

Examining docking interactions on ERK2 with modular peptide substrates

研究ERK2与模块化肽底物的对接相互作用

Lee, Sunbae; Warthaka, Mangalika; Yan, Chunli; Kaoud, Tamer S; Ren, Pengyu; Dalby, Kevin N